Jan Stefan Olofsson

Gjesteforsker

Vitenskapelig artikkel

Vis forfatter(e) (2023). Vaccination prevents severe COVID-19 outcome in patients with neutralizing type 1 interferon autoantibodies. iScience. 18 sider.
Vis forfatter(e) (2023). Risk assessment and antibody responses to SARS-CoV-2 in healthcare workers. Frontiers in Public Health. 13 sider.
Vis forfatter(e) (2023). Post COVID-19 condition after delta infection and omicron reinfection in children and adolescents. EBioMedicine. 10 sider.
Vis forfatter(e) (2023). Durable immune responses after BNT162b2 vaccination in home-dwelling old adults. Vaccine: X. 1-11.

Vis forfatter(e) (2022). The performances of three commercially available assays for the detection of SARS‐CoV‐2 antibodies at different time points following SARS‐CoV‐2 infection. Viruses. 1-11.
Vis forfatter(e) (2022). SARS CoV-2 Infection among Health Care Workers from Different Health Care Facilities in Western Norway: A Prospective, Cross-Sectional Study. Viruses. 8 sider.
Vis forfatter(e) (2022). A rapid antibody screening haemagglutination test for predicting immunity to SARS-CoV-2 variants of concern. Communications Medicine. 11 sider.